Skip to content
Fast Company Executive Board

The Fast Company Executive Board is a private, fee-based network of influential leaders, experts, executives, and entrepreneurs who share their insights with our audience.

The mental health crisis and the future of its care

AI may play a key role in mental healthcare management.

[Photo: Getty Images]

Profile photo of Ronald M. Razmi

Managing Director · Zoi Capital

One of the long-term consequences of the COVID-19 pandemic has been the sharp rise in the prevalence of mental health diseases. This stems from many of the actions taken to minimize the death and suffering from the virus. Lockdowns, school closures, and remote work—all necessary steps in the face of a once-in-a-hundred-year pandemic—resulted in a range of mental health issues that are affecting people across generations. Anxiety, depression, sense of isolation, and more spiked since 2020 and continue to be far more prevalent than their historic numbers. Given the limited number of mental health professionals, this has led to a mismatch between the supply and demand for these resources.

Mental health has historically been managed very differently than physical health issues. For decades, insurance companies had limited coverage for psychiatric diagnoses. The research dollars to study the cause, diagnosis, and treatment of these illnesses were dwarfed in comparison with the physical ailments. Mental health research received 25 times less funding per affected person as compared to physical health conditions, such as cancer. This funding disparity means that our understanding of these illnesses lags significantly and the range of available diagnostic and therapeutic options is limited. This can lead to problems remaining undetected for a long time and result in quiet suffering and performance issues in all facets of life. It can also manifest itself in physical complaints that lead to repeated clinical visits and expensive diagnostic testing.

Mental health has traditionally been challenging for those affected, and for the medical community. For people experiencing psychiatric issues, the stigma attached makes it difficult to seek help. Medical professionals may not feel fully comfortable or be too preoccupied managing other issues in a short visit to screen for it. This is more problematic because there is no good blood or imaging test that can make a definitive diagnosis. While mental health’s impact on the quality of life and the outcome of physical illnesses is undeniable, we still lack definitive tests to diagnose it. This goes back to the earlier point about fewer research dollars have been invested in this area.

DIGITAL BIOMARKERS

As I discuss in my book, AI Doctor, AI may just be the type of tool we need to improve our population’s mental health. There is increasing evidence that using AI, combined with modern data technologies like smartphones generate, we can detect clues to individuals’ mental health. This includes analyzing voice quality, facial expressions, quality of interactions with digital devices, subtle findings on scans such as MRI, and more.

Digital biomarkers, as they are called, will increasingly be part of how we monitor and manage health issues moving forward—physical and mental. In an increasingly digital world, many digital biomarkers will be generated daily and with technology use such as AI, they can be analyzed and acted upon. Analyzing large amounts of diverse data and identifying patterns is AI’s key strength and it may hold the key to breakthroughs for managing mental health issues.

On the diagnostic front, there is increasingly promising research that shows the effectiveness of analyzing digital biomarkers to screen for and diagnose mental health problems. For example, data collected from wearables such as the Oura ring have shown characteristic patterns of sleep and activity for people experiencing depressive episodes. While the initial attempts to treat mental health using AI have been controversial and increasingly face push-back, these are the early days for this technology and we have only begun to test its capabilities in this area.

AI BARRIERS AND PROMISES

Early chatbots used for therapy of psychiatric issues have used large language models trained on all of the internet as their backbone, and not specifically trained for this purpose. As such, mixed results were to be expected. We can expect future iterations that are trained on high-quality medical data and fully tested for safety and effectiveness to perform much better. While this is not meant to replace the human touch, a key element of managing these conditions, it can serve as a human therapist extender and fill in the gaps where there are no resources available to help people in need.

In spite of the many barriers AI faces in its healthcare adoption, it is the only technology that holds the promise to radically transform the experience and quality of care. Its early adoption in certain areas to improve patient experience shows promising results. This can also show a skeptical healthcare workforce about possible tangible benefits for them and their patients from these new technologies. Examples of early impact areas include clinic call center management for easier scheduling and responding to patient issues, helping with the enormous administrative burden such as note writing, fighting with insurance companies for necessary test and procedure approval, and submitting proof of service for payment.  

All of this can help provide relief for an overwhelmed workforce and create breathing room to focus more resources on mental health issues that have usually been deprioritized. Much research needs to happen before the medical community would feel comfortable in fully using technologies like AI for these conditions. However, we have a very high need for breakthroughs in diagnosing and managing mental health issues. The supply of psychiatrists and therapists will remain limited for the near future. While it remains to be seen how AI will eventually become part of the armamentarium in dealing with mental health issues, it is exciting to explore its potential to create new paradigms for these underserved populations.

Ronald Razmi is managing director of Zoi Capital.